Thame Laboratories
Thame Laboratories is a UK-based, privately-held pharmaceutical company that develops, licenses, manufactures, and markets liquid medicines. Founded in 1998 and operating from Ruislip, the firm maintains a small workforce of 11-50 employees across its vertically integrated medicines business.
- Company typePrivate
- Founded1998
- HeadquartersRuislip, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Thame Laboratories does
Thame Laboratories is a privately-held UK pharmaceutical company that develops, licenses, manufactures, and markets liquid medicines. Founded in 1998 and headquartered in Ruislip, United Kingdom, the firm operates with a workforce of 11-50 employees, positioning it as a small-to-mid-sized specialty pharmaceutical operator within the UK medicines supply chain. The company's stated activities — proprietary development, licensing arrangements, in-house manufacturing, and commercial marketing of liquid dosage forms — imply a vertically integrated model spanning formulation through to commercial distribution, although no specific products, brands, therapeutic categories, or pipeline assets are disclosed in the available source material.
Thame Laboratories firmographics
Firmographics- Name
- Thame Laboratories
- Website
- https://thamelabs.co.uk
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Thame Laboratories is a UK-based, privately-held pharmaceutical company that develops, licenses, manufactures, and markets liquid medicines. Founded in 1998 and operating from Ruislip, the firm maintains a small workforce of 11-50 employees across its vertically integrated medicines business.
- Ownership category
- akta.pro rank
Thame Laboratories industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
- akta.pro secondary industry
- Small-Molecule API Process Development & Route Scouting (HLAGAHAA)
Keywords
Where Thame Laboratories is headquartered
LocationHeadquarters
- HQ city
- Ruislip
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
Thame Laboratories business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D
Thame Laboratories product offering
Product offeringCore offering
Thame Laboratories develops, licenses, manufactures, and markets liquid medicines. The company operates as a for-profit, privately held pharmaceutical firm headquartered in Ruislip, United Kingdom, with 11-50 employees. No specific product SKUs, formulations, or branded medicines are disclosed in the available source content.
Product overview
Thame Laboratories maintains a website at thamelabs.co.uk that is currently under scheduled maintenance. No product or service information is available from the source content.
Differentiator
Problem solved
Functional benefit
Companies that use Thame Laboratories
Customer profileIdeal customer profiles1 record
Thame Laboratories technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Thame Laboratories competitors and assessment
Company assessmentDirect peers
- NextPharma: European specialty pharmaceutical manufacturer with a strong footprint in liquid and semi-solid dosage form manufacturing, supplying branded and generic products. Direct operational overlap on liquid dosage forms within European markets.
- Ennogen Healthcare: UK-headquartered specialty pharmaceutical company that develops, licenses, and markets niche medicines including liquid formulations. Comparable vertically integrated model and UK SME scale.
- Genesis Pharmaceuticals: UK-based specialty pharma focused on niche prescription products including liquid formulations. Comparable size, geography, and development-plus-marketing business model.
- Rosemont Pharmaceuticals: UK-based specialist manufacturer of liquid medicines, particularly oral liquids, with a focus on niche therapeutic areas and licensing-driven distribution. Closely comparable by geography, dosage form, and vertically integrated development-to-market model.
- Pinewood Laboratories: Specialty manufacturer of liquid and semi-solid pharmaceutical products based in Ireland, serving UK and international markets. Comparable dosage-form focus and contract/specialty manufacturing orientation.
Broad incumbents
- Almac Group: Global contract pharmaceutical development and manufacturing organisation offering liquid formulation development and commercial manufacturing services. Overlaps in liquid medicine manufacturing but operates as a broad CDMO rather than a niche branded manufacturer.
- Stada Arzneimittel: European-focused specialty and generics pharmaceutical company with broad portfolio across multiple dosage forms, including liquid medicines, distributed across the UK. Indirectly comparable as an incumbent competitor across UK retail and prescription channels.
- Recipharm: Large European CDMO operating pharmaceutical manufacturing facilities including liquid dosage form production across multiple sites. Comparable on manufacturing capability but at vastly greater scale and breadth.
- GlaxoSmithKline: Major UK-headquartered global pharmaceutical company with extensive branded and consumer healthcare liquid medicine product lines across prescription and OTC markets. Competes in the same UK therapeutic and consumer channels despite vastly larger scale.
- Teva Pharmaceutical Industries: World's largest generic medicines manufacturer with extensive liquid and oral dosage-form portfolio across multiple UK distribution channels. Competes with smaller UK liquid-medicine manufacturers for shelf space, tenders, and NHS contracts.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat3 records
Key risks4 records
Key highlights3 records
Customer concentration
Thame Laboratories social profiles
Digital presenceThame Laboratories financial estimates
Financial estimateRevenue estimate
Valuation estimate
Thame Laboratories leadership team
Management profileNumber of profiles
Thame Laboratories funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Thame Laboratories M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Thame Laboratories
What does Thame Laboratories do?
Thame Laboratories develops, licenses, manufactures, and markets liquid medicines. The company operates as a for-profit, privately held pharmaceutical firm headquartered in Ruislip, United Kingdom, with 11-50 employees. No specific product SKUs, formulations, or branded medicines are disclosed in the available source content.
Is Thame Laboratories a public or private company?
Thame Laboratories is a private company. It is classified as unknown and is currently operating.
When was Thame Laboratories founded?
Thame Laboratories was founded in 1998. It employs 11 to 50 people.
Where is Thame Laboratories based?
Thame Laboratories is headquartered in Ruislip, United Kingdom, in the Europe region.
Who are Thame Laboratories's main competitors?
Direct peers on record are NextPharma, Ennogen Healthcare, Genesis Pharmaceuticals, Rosemont Pharmaceuticals and Pinewood Laboratories. Broad incumbents are Almac Group, Stada Arzneimittel, Recipharm, GlaxoSmithKline and Teva Pharmaceutical Industries.
Does Thame Laboratories have an API?
No public API is recorded for Thame Laboratories.
What industry is Thame Laboratories in?
Thame Laboratories's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAGAHAA, Small-Molecule API Process Development & Route Scouting. Its NAICS code is 325412 and its SIC code is 2834.